Anti-CYSLTR2 Polyclonal Antibody
Cat.No:K108957P Solarbio
Reactivity:Human
Application:IHC
Clone Type:Polyclonal Antibody
Storage:Store at -20℃. Avoid freeze/thaw cycles.
Gene ID:57105
Host:Rabbit
Qty:
Size:
{{cart_num}}
My CartReactivity:Human
Application:IHC
Clone Type:Polyclonal Antibody
Storage:Store at -20℃. Avoid freeze/thaw cycles.
Gene ID:57105
Host:Rabbit
Qty:
Size:
Name | Anti-CYSLTR2 Polyclonal Antibody |
Host | Rabbit |
Clone Type | Polyclonal Antibody |
Subtype | IgG |
Dilution Ratio | IHC 1:25-100. |
Target | CYSLTR2 |
Background | The cysteinyl leukotrienes LTC4, LTD4, and LTE4 are important mediators of human bronchial asthma. Pharmacologic studies have determined that cysteinyl leukotrienes activate at least 2 receptors, the protein encoded by this gene and CYSLTR1. This encoded receptor is a member of the superfamily of G protein-coupled receptors. It seems to play a major role in endocrine and cardiovascular systems. |
Swiss Prot | Q9NS75 |
Gene ID | 57105 |
Subcellular Location | Cytoplasm |
Immunogen | A synthetic peptide of human CYSLTR2 |
Public Immunogen Range | 295-345/346aa |
Calculated MW | 40/39/35kDa |
Purification Method | Octanoic acid-ammonium sulfate precipitation |
Storage Buffer | PBS with 50% Glycerol,0.03% Proclin300,0.5% BSA,pH 7.3. |
Storage | Store at -20℃. Avoid freeze/thaw cycles. |
Unit | Piece |
Specification | 20ul 50ul 100ul |
Reactivity | Human |
Application | IHC |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Kindly reminder:Quick spin before use. If you have any questions, please contact us.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.